« Previous
Next »
Titles
- S12 nonclinical biodistribution considerations for gene therapy products: guidance for industry1
- Severe maternal morbidity in Pennsylvania1
- Smoking cessation and related indications: developing nicotine replacement therapy drug products : guidance for industry1
- Social Security's finances: testimony before the Subcommittee on Social Security, Committee on Ways and Means, U.S. House of Representatives1
- Social needs screening among non-federal acute care hospitals, 20221
- Soft (hydrophilic) daily wear contact lenses: performance criteria for safety and performance based pathway : guidance for industry and Food and Drug Administration staff1
- Some skin substitute manufacturers did not comply with new ASP reporting requirements1
- South Dakota MMIS and E&E system security controls were partially effective and improvements are needed1
- State all payer claims databases: identifying challenges and opportunities for conducting patient-centered outcomes research and multi-state studies1
- State-based recommendations to support rural ambulance agencies1
- States face ongoing challenges in meeting third-party liability requirements for ensuring that Medicaid functions as the payer of last resort1
- Strengthening the integrated care workforce1
- Submitting clinical trial datasets and documentation for clinical outcome assessments using Item Response Theory: guidance for industry : technical specifications document1
- Submitting patient-reported outcome data in cancer clinical trials: guidance for industry : technical specifications document1
- Surging the public health workforce: lessons learned from the COVID-19 response at state, tribal, local, and territorial public health agencies1
- Surveying, leveling, and alignment laser products: guidance for industry and Food and Drug Administration staff1